Back to search

Article

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard

2021-05-12

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Multiple anti-SARS-CoV-2 immunoassays are available, but no gold standard exists. We assessed four assays using various methodological approaches to estimate SARS-COV-2 seroprevalence during the first COVID-19 wave in Canada. <h4>Methods</h4> This serial cross-sectional study was conducted using plasma samples from healthy blood donors between April-September 2020. Qualitative...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2c3979c1-7653-59e7-a847-03fb69a994ce
DOI
10.1101/2021.05.11.21256992
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standardDOI 10.1101/2021.05.11.21256992
Select a neighboring publication to make it the new centre.